Capital World Investors
RVMD icon

Capital World Investors’s Revolution Medicines RVMD Stock Holding History

Capital World Investors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$751M Buy
+4,008,244
New +$585M 0.09% 178
2022
Q2 		– Sell
-1,228,000
Closed -$31.3M – 586
2022
Q1 		$31.3M Hold
1,228,000
– – 0.01% 463
2021
Q4 		$30.9M Hold
1,228,000
– – ﹤0.01% 499
2021
Q3 		$33.8M Hold
1,228,000
– – 0.01% 495
2021
Q2 		$39M Hold
1,228,000
– – 0.01% 474
2021
Q1 		$56.3M Hold
1,228,000
– – 0.01% 422
2020
Q4 		$48.6M Hold
1,228,000
– – 0.01% 409
2020
Q3 		$42.7M Buy
1,228,000
+307,547
+33% +$8.52M 0.01% 405
2020
Q2 		$29.1M Buy
920,453
+50,919
+6% +$1.6M 0.01% 403
2020
Q1 		$19.1M Buy
+869,534
New +$24.1M 0.01% 403

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Capital World Investors's RVMD Position: Q2 2026 in Review

Capital World Investors opened a new position in Revolution Medicines (RVMD) in Q2 2026: 4,008,244 shares worth $751M. The stake represents 0.09% of the portfolio and ranks #178 among its holdings. This is a return to the name: Capital World Investors previously reported a position in RVMD as recently as Q1 2022.

Capital World Investors first reported a position in RVMD in Q1 2020 and has held it in 10 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Capital World Investors held 4,008,244 shares of Revolution Medicines worth $751M as of Q2 2026.
  • Revolution Medicines was a new Capital World Investors position in Q2 2026.
  • Revolution Medicines made up 0.09% of Capital World Investors's portfolio in Q2 2026, its #178 holding.
  • Capital World Investors first reported a position in Revolution Medicines in Q1 2020 and has held it in 10 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.